LOBAMINE CYSTEINE, hard capsule 120 capsules
Active ingredients: Cysteine hydrochloride, DL-MÉTHIONINE
Commercialized according to BDPM
Hard capsule120 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOBAMINE CYSTEINE, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 12 plaquette(s) PVC-Aluminium de 10 gélule(s)
- Marketing authorisation holder
- PIERRE FABRE MEDICAMENT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Feb 2026
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69896201CIP73646240CIP133400936462403Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE CYSTÉINE ANHYDREgélule | 150 mg · une gélule | SA |
| DL-MÉTHIONINEgélule | 350 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.